Conditions: HIV Infection Gastrointestinal Symptoms
Keywords: AIDS Acquired Immunodeficiency Syndrome HIV Human Immunodeficiency Virus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
Improvement in the rate of bacterial translocation may lead to a decrease in a chronic inflammatory response thereby decreasing CD4 destruction and HIV proliferation.

By the addition of probiotics we hope to show a reduction in LPS leading to a decrease in chronic inflammation and therefore an improvement in immune markers.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: GanedenBC30, GBI-30, PTA-6086 intervention 2: Placebo
Intervention descriptions: intervention 1: 1 capsule per day containing 2 billion CFU of GanedenBC30, GBI-30, PTA-6086 for 90 days. intervention 2: 1 capsule per day for 90 days.

Protocol document: